Aşırı Aktif Mesane Hastalarının Afektif Mizaç Özellikleri

Kaynakça (1)

1. Sarıbacak A, Altınbaş K, Yılmaz H, Özkan A, Özkan L, Oral T. Affective temperament profiles of overactive bladder patients. Arch Neuropsychiatr 2014; 51:263-266. [CrossRef] 2. Abrams P, Cardozo L, Fall M, Griffiths D, Rosier P, Ulmsten U, van Kerrebroeck P, Victor A, Wein A; Standardisation Sub-committee of the International Continence Society. The standardisation of terminology of lower urinary tract function: report from the Standardisation Sub-committee of the International Continence Society. Neurourol Urodyn 2002; 21:167-178. [CrossRef] 3. Kulaksızoğlu H. Botulinum Toxin Applications in Overactive Bladder Symptoms Secondary to Neurological Diseases. Arch Neuropsychiatr 2010; 47:44-47. 4. Gormley EA, Lightner DJ, Burgio KL, Chai TC, Clemens JQ, Culkin DJ, Das AK, Foster HE Jr, Scarpero HM, Tessier CD, Vasavada SP. Diagnosis and treatment of overactive bladder (non-neurogenic) in adults: AUA/SUFU guideline. J Urol 2012; 188:2455-2463. [CrossRef] 5. Steers WD. Pathophysiology of overactive bladder and urge urinary İncontinence. Rev Urol 2002; 4:7-18. 6. de Groat WC. Influence of central serotonergic mechanisms on lower urinary tract function. Urology 2002; 59:30-36. [CrossRef] 7. Uebersax JS, Wyman JF, Shumaker SA, McClish DK, Fantl AJ. Short forms to assess life quality and symptom distress for urinary incontinence in women: the incontinence impact questionnaire and the urogenital distress inventory. Neurourol Urodyn 1995; 14:131-139. [CrossRef] 8. Cam C, Karateke A, Sakallı M. Validation of the short forms of Incontinence Impact Questionnaire (IIQ-7) and Urogenital Distress Inventory (UDI-6) in a Turkısh Population. Neurourol Urodyn 2007; 26:129-133. [CrossRef